Cubist Pharmaceuticals Issues Voluntary Recall Of Cubicin

Cubist Pharmaceuticals announced that it has issued a voluntary recall of one lot of Cubicin (daptomycin for injection) due to the presence of particulate matter, identified specifically as glass particles.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news